Literature DB >> 8396669

Chimeric hepatitis B virus core particles with parts or copies of the hepatitis C virus core protein.

A Yoshikawa1, T Tanaka, Y Hoshi, N Kato, K Tachibana, H Iizuka, A Machida, H Okamoto, M Yamasaki, Y Miyakawa.   

Abstract

Either parts or multiple copies of the core gene of hepatitis C virus (HCV) were fused to the 3' terminus of the hepatitis B virus (HBV) core gene with 34 codons removed. As many as four copies of HCV core protein (720 amino acids) were fused to the carboxy terminus of truncated HBV core protein (149 amino acids) without preventing the assembly of HBV core particles. Chimeric core particles were sandwiched between monoclonal antibody to HBV core and that to HCV core, thereby indicating that antigenic determinants of both HBV and HCV cores were accessible on them. Proteolytic digestion deprived chimeric core particles of the antigenicity for the HCV core without affecting that of the HBV core, confirming the surface exposure of HCV core determinants. The density of HCV core determinants on chimeric core particles increased as copies of fused HCV core protein were increased. Hybrid core particles with multiple HCV core determinants would be instrumental as an antigen probe for detecting class-specific antibodies to the HCV core in patients with acute and chronic hepatitis C and for simultaneous detection of antibodies to HBV core and those to HCV core in donated blood.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396669      PMCID: PMC238027     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein.

Authors:  B E Clarke; S E Newton; A R Carroll; M J Francis; G Appleyard; A D Syred; P E Highfield; D J Rowlands; F Brown
Journal:  Nature       Date:  1987 Nov 26-Dec 2       Impact factor: 49.962

2.  Immune response to hepatitis B virus core antigen (HBcAg): localization of T cell recognition sites within HBcAg/HBeAg.

Authors:  D R Milich; A McLachlan; A Moriarty; G B Thornton
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

3.  Immunogenicity of peptide fusions to hepatitis B virus core antigen.

Authors:  S J Stahl; K Murray
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

4.  Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes.

Authors:  H Okamoto; F Tsuda; H Sakugawa; R I Sastrosoewignjo; M Imai; Y Miyakawa; M Mayumi
Journal:  J Gen Virol       Date:  1988-10       Impact factor: 3.891

5.  Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay.

Authors:  S Kleinman; H Alter; M Busch; P Holland; G Tegtmeier; M Nelles; S Lee; E Page; J Wilber; A Polito
Journal:  Transfusion       Date:  1992 Nov-Dec       Impact factor: 3.157

6.  Demonstration of two distinct antigenic determinants on hepatitis B e antigen by monoclonal antibodies.

Authors:  M Imai; M Nomura; T Gotanda; T Sano; K Tachibana; H Miyamoto; K Takahashi; S Toyama; Y Miyakawa; M Mayumi
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

7.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

8.  Protection against hepatitis B virus infection by immunization with hepatitis B core antigen.

Authors:  S Iwarson; E Tabor; H C Thomas; P Snoy; R J Gerety
Journal:  Gastroenterology       Date:  1985-03       Impact factor: 22.682

9.  A model for the hepatitis B virus core protein: prediction of antigenic sites and relationship to RNA virus capsid proteins.

Authors:  P Argos; S D Fuller
Journal:  EMBO J       Date:  1988-03       Impact factor: 11.598

10.  Hepatitis B virus antigens made in microbial cells immunise against viral infection.

Authors:  K Murray; S A Bruce; A Hinnen; P Wingfield; P M van Erd; A de Reus; H Schellekens
Journal:  EMBO J       Date:  1984-03       Impact factor: 11.598

View more
  8 in total

1.  The morphogenic linker peptide of HBV capsid protein forms a mobile array on the interior surface.

Authors:  Norman R Watts; James F Conway; Naiqian Cheng; Stephen J Stahl; David M Belnap; Alasdair C Steven; Paul T Wingfield
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

2.  A theoretical model for the dynamic structure of hepatitis B nucleocapsid.

Authors:  Dong Meng; Rex P Hjelm; Jianming Hu; Jianzhong Wu
Journal:  Biophys J       Date:  2011-11-15       Impact factor: 4.033

3.  Epitope-distal effects accompany the binding of two distinct antibodies to hepatitis B virus capsids.

Authors:  Jessica Z Bereszczak; Rebecca J Rose; Esther van Duijn; Norman R Watts; Paul T Wingfield; Alasdair C Steven; Albert J R Heck
Journal:  J Am Chem Soc       Date:  2013-04-18       Impact factor: 15.419

Review 4.  Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C.

Authors:  Makutiro Ghislain Masavuli; Danushka K Wijesundara; Joseph Torresi; Eric J Gowans; Branka Grubor-Bauk
Journal:  Front Microbiol       Date:  2017-12-05       Impact factor: 5.640

5.  Multiple roles of core protein linker in hepatitis B virus replication.

Authors:  Kuancheng Liu; Laurie Luckenbaugh; Xiaojun Ning; Ji Xi; Jianming Hu
Journal:  PLoS Pathog       Date:  2018-05-21       Impact factor: 6.823

Review 6.  HCV Glycoprotein Structure and Implications for B-Cell Vaccine Development.

Authors:  Luisa J Ströh; Thomas Krey
Journal:  Int J Mol Sci       Date:  2020-09-16       Impact factor: 5.923

7.  Production of the HBc Protein from Different HBV Genotypes in E. coli. Use of Reassociated HBc VLPs for Packaging of ss- and dsRNA.

Authors:  Ivars Petrovskis; Ilva Lieknina; Andris Dislers; Juris Jansons; Janis Bogans; Inara Akopjana; Jelena Zakova; Irina Sominskaya
Journal:  Microorganisms       Date:  2021-01-30

8.  Efficient cellular and humoral immune response and production of virus-neutralizing antibodies by the Hepatitis B Virus S/preS116-42 antigen.

Authors:  Ana-Maria Pantazica; Mihaela-Olivia Dobrica; Catalin Lazar; Cristina Scurtu; Catalin Tucureanu; Iuliana Caras; Irina Ionescu; Adriana Costache; Adrian Onu; Jihong Liu Clarke; Crina Stavaru; Norica Branza-Nichita
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.